{"id":784802,"date":"2023-09-19T07:32:30","date_gmt":"2023-09-19T11:32:30","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\/"},"modified":"2023-09-19T07:32:30","modified_gmt":"2023-09-19T11:32:30","slug":"athira-pharma-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\/","title":{"rendered":"Athira Pharma to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference"},"content":{"rendered":"
\n

BOTHELL, Wash., Sept. 19, 2023 (GLOBE NEWSWIRE) — Athira Pharma, Inc.<\/u><\/a>\u00a0(NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced that Company management will participate in a panel presentation at the 2023 Cantor Fitzgerald Global Healthcare Conference taking place from September 26-28, 2023 in New York City. Details are as follows:<\/p>\n

\n 2023 Cantor Fitzgerald Global Healthcare Conference <\/strong>
\n
Panel Presentation Date and Time: Tuesday, September 26, 2023, from 10:30 am \u2013 11:00 am ET
Location: InterContinental Barclay Hotel<\/p>\n

A live webcast of the panel presentation can be accessed from the Investors section of the Athira website at https:\/\/investors.athira.com\/news-and-events\/events-and-presentations-investor<\/u><\/a>. An archived replay of the webcasts will be available for at least 30 days following the event.<\/p>\n

\n About Athira Pharma, Inc.<\/strong>
\n
Athira Pharma, Inc., headquartered in the Seattle, Washington area, is a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration. Athira aims to alter the course of neurological disease by advancing its pipeline of therapeutic candidates targeting the HGF\/MET neurotrophic system for Alzheimer\u2019s and Parkinson\u2019s disease, Dementia with Lewy bodies, and amyotrophic lateral sclerosis. For more information, visit\u00a0www.athira.com<\/u><\/a>. You can also follow Athira on\u00a0Facebook<\/u><\/a>,\u00a0LinkedIn<\/u><\/a>\u00a0and @athirapharma on\u00a0X<\/u><\/a>, formerly known as\u00a0Twitter<\/u><\/a>,\u00a0and\u00a0Instagram<\/u><\/a>.<\/p>\n

\n Investor & Media Contact:<\/strong>\n <\/p>\n

Julie Rathbun
Athira Pharma
Julie.rathbun@athira.com<\/u><\/a>
206-769-9219<\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

BOTHELL, Wash., Sept. 19, 2023 (GLOBE NEWSWIRE) — Athira Pharma, Inc.\u00a0(NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced that Company management will participate in a panel presentation at the 2023 Cantor Fitzgerald Global Healthcare Conference taking place from September 26-28, 2023 in New York City. Details are as follows: 2023 Cantor Fitzgerald Global Healthcare Conference Panel Presentation Date and Time: Tuesday, September 26, 2023, from 10:30 am \u2013 11:00 am ETLocation: InterContinental Barclay Hotel A live webcast of the panel presentation can be accessed from the Investors section of the Athira website at https:\/\/investors.athira.com\/news-and-events\/events-and-presentations-investor. An archived replay of the webcasts will be available for at least 30 … <\/p>\n

Continue reading “Athira Pharma to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-784802","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nAthira Pharma to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Athira Pharma to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BOTHELL, Wash., Sept. 19, 2023 (GLOBE NEWSWIRE) — Athira Pharma, Inc.\u00a0(NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced that Company management will participate in a panel presentation at the 2023 Cantor Fitzgerald Global Healthcare Conference taking place from September 26-28, 2023 in New York City. Details are as follows: 2023 Cantor Fitzgerald Global Healthcare Conference Panel Presentation Date and Time: Tuesday, September 26, 2023, from 10:30 am \u2013 11:00 am ETLocation: InterContinental Barclay Hotel A live webcast of the panel presentation can be accessed from the Investors section of the Athira website at https:\/\/investors.athira.com\/news-and-events\/events-and-presentations-investor. An archived replay of the webcasts will be available for at least 30 … Continue reading "Athira Pharma to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-19T11:32:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyNDU1NiM1ODIwOTgwIzIyMDE4OTE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athira-pharma-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athira-pharma-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Athira Pharma to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference\",\"datePublished\":\"2023-09-19T11:32:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athira-pharma-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\\\/\"},\"wordCount\":236,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athira-pharma-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyNDU1NiM1ODIwOTgwIzIyMDE4OTE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athira-pharma-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athira-pharma-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\\\/\",\"name\":\"Athira Pharma to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athira-pharma-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athira-pharma-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyNDU1NiM1ODIwOTgwIzIyMDE4OTE=\",\"datePublished\":\"2023-09-19T11:32:30+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athira-pharma-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athira-pharma-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athira-pharma-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyNDU1NiM1ODIwOTgwIzIyMDE4OTE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyNDU1NiM1ODIwOTgwIzIyMDE4OTE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athira-pharma-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Athira Pharma to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Athira Pharma to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Athira Pharma to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference - Market Newsdesk","og_description":"BOTHELL, Wash., Sept. 19, 2023 (GLOBE NEWSWIRE) — Athira Pharma, Inc.\u00a0(NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced that Company management will participate in a panel presentation at the 2023 Cantor Fitzgerald Global Healthcare Conference taking place from September 26-28, 2023 in New York City. Details are as follows: 2023 Cantor Fitzgerald Global Healthcare Conference Panel Presentation Date and Time: Tuesday, September 26, 2023, from 10:30 am \u2013 11:00 am ETLocation: InterContinental Barclay Hotel A live webcast of the panel presentation can be accessed from the Investors section of the Athira website at https:\/\/investors.athira.com\/news-and-events\/events-and-presentations-investor. An archived replay of the webcasts will be available for at least 30 … Continue reading \"Athira Pharma to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2023-09-19T11:32:30+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyNDU1NiM1ODIwOTgwIzIyMDE4OTE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Athira Pharma to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference","datePublished":"2023-09-19T11:32:30+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\/"},"wordCount":236,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyNDU1NiM1ODIwOTgwIzIyMDE4OTE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\/","name":"Athira Pharma to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyNDU1NiM1ODIwOTgwIzIyMDE4OTE=","datePublished":"2023-09-19T11:32:30+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyNDU1NiM1ODIwOTgwIzIyMDE4OTE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyNDU1NiM1ODIwOTgwIzIyMDE4OTE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-to-participate-in-the-2023-cantor-fitzgerald-global-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Athira Pharma to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/784802","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=784802"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/784802\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=784802"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=784802"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=784802"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}